Gamma Globulin Market Report - (Growth and Size 2031)
The Gamma Globulin Market is expected to register a CAGR of 7.2% from 2023 to 2031, with a market size expanding from US$ XX million in 2023 to US$ XX Million by 2031.
The report is segmented By Product Type (Injection, Lyophilized powder); Application (Neurological and neuromuscular disease treatment, Central nervous system disease treatment, Peripheral nerves disease treatment, Neuromuscular junction and muscles disease treatment). The global analysis is further broken-down at regional level and major countries. The Report Offers the Value in USD for the above analysis and segments.
Purpose of the ReportThe report Gamma Globulin Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:
- Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
- Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
- Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.
Gamma Globulin Market Segmentation
Product Type- Injection
- Lyophilized powder
- Neurological and neuromuscular disease treatment
- Central nervous system disease treatment
- Peripheral nerves disease treatment
- Neuromuscular junction and muscles disease treatment
Strategic Insights
Gamma Globulin Market Growth Drivers- Rising Incidence of Immune Disorders: Diseases such as primary immunodeficiencies and autoimmune disorders are pushing patients toward gamma globulin, thereby augmenting the number of gamma-globulin requirements because many of these patients necessitate immunoglobulin replacement therapies for management. Hence, the increasing prevalence of patients has to growth in the market and urge new investments in the most innovative areas of gamma globulin therapy.
- Advancements in Biotechnology and Medical Research: Gamma globulin treatments have gained efficacy and improved safety over previous treatments due to the continuous developments in biotechnology and medical research. It has also facilitated the development of newer formulations that will have fewer adverse effects and better therapeutic results for patients, thus increasing the demand for gamma globulin therapies. Such innovations will augment the field of gamma globulin usage in contemporary medicine further with increasing research on immunoglobulin-based therapy for many other indications.
- Expanding Healthcare Infrastructure in Emerging Markets: The emerging healthcare infrastructure in many developing countries, particularly Asia Pacific and Latin America, offers new avenues for gamma globulin therapies. Growth in general access in healthcare services triggered by economic development in these regions pushes a demand for advanced medical treatments such as gamma globulin and grows the market in these regions.
- Shift Towards Home Infusion Therapies: Increasingly in the gamma globulin market, the treatment is shifting to at-home infusion therapies. People suffering from immunodeficiencies are now using home infusion instead of being hospitalized. The factors that have motivated this change include improvements in subcutaneous infusion techniques, ease of use by patients, and flexible options that save on treatment costs through enhanced convenience of care.
- Personalized Medicine Approach: The personalized medicine approach is another major trend impacting the gamma globulin market. More persuasive is the therapy customization for immunoglobulins related to individual cases, conditions, and genetic profiles. It guarantees better effectiveness and less side effects, in that it creates a need for personal gamma globulin in a variety of patient cases leading to a better outcome.
- Increase in Preventive Care and Early Diagnosis: Also, boosting this gamma globulin market will be the shifting level towards preventive care and early diagnosis of immune-related diseases. With readily available new and better diagnostic tools and new kinds of screening, it becomes easier today to detect such diseases as early as possible and thus requires the application of immunoglobulin therapy. The shift in this direction toward more preventive health care is likely to broaden the patient base and create more opportunities for gamma globulin administered in the average daily practice.
- Emerging Markets Expansion: Increasing healthcare investments in emerging economies like India, China, and regions like Latin America present an even larger opportunity for the gamma globulin market. These countries are improving healthcare access and infrastructure; therefore, the number of immunoglobulin therapies is going to increase with time in such areas where immune deficiency and autoimmune diseases are rampant.
- Development of Novel Immunoglobulin Products: Changing requirements for treatments have prompted the development of new gamma globulin entities. Advances of biotechnology allow for new formulations-such as subcutaneous immunoglobulin therapy-increasing safety measures in patient care and many more to enhance outcome reports that will widen therapeutic options with gamma globulin therapy.
- Increased Adoption in Rare Diseases: There is now a noticeable rise in gamma globulin therapy concerning treatment for rare diseases and chronic inflammatory demyelinating polyneuropathy as well as other neurological disorders. Specific gamma globulin therapies are likely to grow even more popular with increasing awareness, and better diagnostics will create specialized niches within the already broad healthcare market.
Market Report Scope
Key Selling Points
- Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Gamma Globulin Market, providing a holistic landscape.
- Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
- Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
- Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.
The research report on the Gamma Globulin Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.
REGIONAL FRAMEWORK
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The market is expected to grow at a CAGR of 7.2%
Rising incidence of immune disorders and advancements in biotechnology and medical research is the major factors boosting the gamma globulin market growth
Asia Pacific is estimated to grow at the highest CAGR over the forecast year (2023 - 2031)
The North America region accounts for highest revenue share gamma globulin market
The final report will duly include market size and projection estimates for all the segments from 2021 to 2031, along with a revenue share and compound annual growth rate (%) for the regional
/
country-wise market wherein 2021-2022 are the historic years, 2023 is considered to be the base year, and the forecast will be provided till 2031, along with CAGR (%)
Grifols, S.A., Baxter, Octapharma AG, Biotest AG, Kedrion S.p.A, ADMA Biologics, Inc., Merck KGaA, Takeda Pharmaceutical Company Limited, Bio Products Laboratory, OCTAPHARMA Pharmazeutika Produktionsges.m.b.H are the some of the key market players operating in the gamma globulin market
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Gamma Globulin Market - By Product Type
1.3.2 Gamma Globulin Market - By Application
1.3.3 Gamma Globulin Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. GAMMA GLOBULIN MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. GAMMA GLOBULIN MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. GAMMA GLOBULIN MARKET - GLOBAL MARKET ANALYSIS
6.1. GAMMA GLOBULIN - GLOBAL MARKET OVERVIEW
6.2. GAMMA GLOBULIN - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. GAMMA GLOBULIN MARKET - REVENUE AND FORECASTS TO 2028 - PRODUCT TYPE
7.1. OVERVIEW
7.2. PRODUCT TYPE MARKET FORECASTS AND ANALYSIS
7.3. INJECTION
7.3.1. Overview
7.3.2. Injection Market Forecast and Analysis
7.4. LYOPHILIZED POWDER
7.4.1. Overview
7.4.2. Lyophilized powder Market Forecast and Analysis
8. GAMMA GLOBULIN MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. NEUROLOGICAL AND NEUROMUSCULAR DISEASE TREATMENT
8.3.1. Overview
8.3.2. Neurological and neuromuscular disease treatment Market Forecast and Analysis
8.4. CENTRAL NERVOUS SYSTEM DISEASE TREATMENT
8.4.1. Overview
8.4.2. Central nervous system disease treatment Market Forecast and Analysis
8.5. PERIPHERAL NERVES DISEASE TREATMENT
8.5.1. Overview
8.5.2. Peripheral nerves disease treatment Market Forecast and Analysis
8.6. NEUROMUSCULAR JUNCTION AND MUSCLES DISEASE TREATMENT
8.6.1. Overview
8.6.2. Neuromuscular junction and muscles disease treatment Market Forecast and Analysis
9. GAMMA GLOBULIN MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Gamma Globulin Market Overview
9.1.2 North America Gamma Globulin Market Forecasts and Analysis
9.1.3 North America Gamma Globulin Market Forecasts and Analysis - By Product Type
9.1.4 North America Gamma Globulin Market Forecasts and Analysis - By Application
9.1.5 North America Gamma Globulin Market Forecasts and Analysis - By Countries
9.1.5.1 United States Gamma Globulin Market
9.1.5.1.1 United States Gamma Globulin Market by Product Type
9.1.5.1.2 United States Gamma Globulin Market by Application
9.1.5.2 Canada Gamma Globulin Market
9.1.5.2.1 Canada Gamma Globulin Market by Product Type
9.1.5.2.2 Canada Gamma Globulin Market by Application
9.1.5.3 Mexico Gamma Globulin Market
9.1.5.3.1 Mexico Gamma Globulin Market by Product Type
9.1.5.3.2 Mexico Gamma Globulin Market by Application
9.2. EUROPE
9.2.1 Europe Gamma Globulin Market Overview
9.2.2 Europe Gamma Globulin Market Forecasts and Analysis
9.2.3 Europe Gamma Globulin Market Forecasts and Analysis - By Product Type
9.2.4 Europe Gamma Globulin Market Forecasts and Analysis - By Application
9.2.5 Europe Gamma Globulin Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Gamma Globulin Market
9.2.5.1.1 Germany Gamma Globulin Market by Product Type
9.2.5.1.2 Germany Gamma Globulin Market by Application
9.2.5.2 France Gamma Globulin Market
9.2.5.2.1 France Gamma Globulin Market by Product Type
9.2.5.2.2 France Gamma Globulin Market by Application
9.2.5.3 Italy Gamma Globulin Market
9.2.5.3.1 Italy Gamma Globulin Market by Product Type
9.2.5.3.2 Italy Gamma Globulin Market by Application
9.2.5.4 Spain Gamma Globulin Market
9.2.5.4.1 Spain Gamma Globulin Market by Product Type
9.2.5.4.2 Spain Gamma Globulin Market by Application
9.2.5.5 United Kingdom Gamma Globulin Market
9.2.5.5.1 United Kingdom Gamma Globulin Market by Product Type
9.2.5.5.2 United Kingdom Gamma Globulin Market by Application
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Gamma Globulin Market Overview
9.3.2 Asia-Pacific Gamma Globulin Market Forecasts and Analysis
9.3.3 Asia-Pacific Gamma Globulin Market Forecasts and Analysis - By Product Type
9.3.4 Asia-Pacific Gamma Globulin Market Forecasts and Analysis - By Application
9.3.5 Asia-Pacific Gamma Globulin Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Gamma Globulin Market
9.3.5.1.1 Australia Gamma Globulin Market by Product Type
9.3.5.1.2 Australia Gamma Globulin Market by Application
9.3.5.2 China Gamma Globulin Market
9.3.5.2.1 China Gamma Globulin Market by Product Type
9.3.5.2.2 China Gamma Globulin Market by Application
9.3.5.3 India Gamma Globulin Market
9.3.5.3.1 India Gamma Globulin Market by Product Type
9.3.5.3.2 India Gamma Globulin Market by Application
9.3.5.4 Japan Gamma Globulin Market
9.3.5.4.1 Japan Gamma Globulin Market by Product Type
9.3.5.4.2 Japan Gamma Globulin Market by Application
9.3.5.5 South Korea Gamma Globulin Market
9.3.5.5.1 South Korea Gamma Globulin Market by Product Type
9.3.5.5.2 South Korea Gamma Globulin Market by Application
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Gamma Globulin Market Overview
9.4.2 Middle East and Africa Gamma Globulin Market Forecasts and Analysis
9.4.3 Middle East and Africa Gamma Globulin Market Forecasts and Analysis - By Product Type
9.4.4 Middle East and Africa Gamma Globulin Market Forecasts and Analysis - By Application
9.4.5 Middle East and Africa Gamma Globulin Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Gamma Globulin Market
9.4.5.1.1 South Africa Gamma Globulin Market by Product Type
9.4.5.1.2 South Africa Gamma Globulin Market by Application
9.4.5.2 Saudi Arabia Gamma Globulin Market
9.4.5.2.1 Saudi Arabia Gamma Globulin Market by Product Type
9.4.5.2.2 Saudi Arabia Gamma Globulin Market by Application
9.4.5.3 U.A.E Gamma Globulin Market
9.4.5.3.1 U.A.E Gamma Globulin Market by Product Type
9.4.5.3.2 U.A.E Gamma Globulin Market by Application
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Gamma Globulin Market Overview
9.5.2 South and Central America Gamma Globulin Market Forecasts and Analysis
9.5.3 South and Central America Gamma Globulin Market Forecasts and Analysis - By Product Type
9.5.4 South and Central America Gamma Globulin Market Forecasts and Analysis - By Application
9.5.5 South and Central America Gamma Globulin Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Gamma Globulin Market
9.5.5.1.1 Brazil Gamma Globulin Market by Product Type
9.5.5.1.2 Brazil Gamma Globulin Market by Application
9.5.5.2 Argentina Gamma Globulin Market
9.5.5.2.1 Argentina Gamma Globulin Market by Product Type
9.5.5.2.2 Argentina Gamma Globulin Market by Application
10. IMPACT OF COVID-19 PANDEMIC ON GLOBAL GAMMA GLOBULIN MARKET
10.1 North America
10.2 Europe
10.3 Asia-Pacific
10.4 Middle East and Africa
10.5 South and Central America
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. GAMMA GLOBULIN MARKET, KEY COMPANY PROFILES
12.1. GRIFOLS, S.A.
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. BAXTER
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. OCTAPHARMA AG
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. BIOTEST AG
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. KEDRION S.P.A
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. ADMA BIOLOGICS, INC.
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. MERCK KGAA
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. TAKEDA PHARMACEUTICAL COMPANY LIMITED
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. BIO PRODUCTS LABORATORY
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. OCTAPHARMA PHARMAZEUTIKA PRODUKTIONSGES.M.B.H
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
1. Grifols, S.A.
2. Baxter
3. Octapharma AG
4. Biotest AG
5. Kedrion S.p.A
6. ADMA Biologics, Inc.
7. Merck KGaA
8. Takeda Pharmaceutical Company Limited
9. Bio Products Laboratory
10. OCTAPHARMA Pharmazeutika Produktionsges.m.b.H
11. Hualan Biological Engineering Inc.
12. Omrix Biopharmaceuticals Ltd.
13. Behring GmbH
14. Shanghai RAAS Blood Products Co., Ltd.
15. Option Care Enterprises, Inc.
16. ADMA Biologics, Inc.,
17. BioScrip, Inc.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For